The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and the liver is under the control of an enzyme called FM o3 it gets flavin flavin mono oxygenase 3 that enzyme is under the control of insulin and so people who are insulin resistant have higher levels of insulin and make more FM o3 so it would follow that those who are insulin resistant would have a higher level of TMAO
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.